Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds
- 31 August 2010
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 175 (1) , 21-29
- https://doi.org/10.1016/j.molbiopara.2010.08.005
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Use of thermal melt curves to assess the quality of enzyme preparationsAnalytical Biochemistry, 2010
- Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase geneMolecular and Biochemical Parasitology, 2009
- Probing the multifactorial basis of Plasmodium falciparum quinine resistance: Evidence for a strain-specific contribution of the sodium-proton exchanger PfNHEMolecular and Biochemical Parasitology, 2009
- Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2009
- Myristoylated adenylate kinase-2 of Plasmodium falciparum forms a heterodimer with myristoyltransferaseMolecular and Biochemical Parasitology, 2009
- Bisphosphonate Inhibition of aPlasmodiumFarnesyl Diphosphate Synthase and a General Method for Predicting Cell-Based Activity from Enzyme DataJournal of Medicinal Chemistry, 2008
- Genomic-scale prioritization of drug targets: the TDR Targets databaseNature Reviews Drug Discovery, 2008
- Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model ValidationJournal of Medicinal Chemistry, 2008
- In vitro evaluations of antimalarial drugs and their relevance to clinical outcomesInternational Journal for Parasitology, 2008
- Transporters involved in resistance to antimalarial drugsTrends in Pharmacological Sciences, 2006